Assessment & Induction
Admission to our program begins with a health and substance use disorder assessment, then the medical team will guide you through induction if deemed appropriate. This may include the use of MAT (medication assisted treatment) such as buprenorphine (Suboxone, Zubsolv, Bunavail, etc). You may also receive other medications (both prescription and over-the-counter) to further manage withdrawal.
If it is determined that the correct medication regimen for you includes buprenorphine, you will likely have the first dose in the office observed to ensure tolerance and dosing. The medical team will evaluate your stability and at that point determine how much medication will be prescribed. Your first prescription will usually be for approximately a 7 day period, and ensure that you have enough medication THROUGH THE FOLLOWING WEDNESDAY (as seen in the example below).
Buprenorphine prescriptions are commonly written on 7, 14, and 28-day cycles. Prescriptions are usually available at the pharmacy by Wednesday at 3:00 p.m. The length of the prescription is determined by:
- The amount of time you have been in the BrightView program
- Your compliance with your individualized treatment plan including appropriate attendance and cessation of drug use
IMPORTANT: Extra medication will not be prescribed if you choose to take buprenorphine (MAT) differently than how it was prescribed or if the medication is stolen or given to another individual. In addition, any of these actions can result in your dismissal from the program. If you miss a medical visit, we will do our best to reschedule you promptly, but it is possibly that your medications may not be issued on the regular schedule.
The admitting provider will write your prescriptions for the first few weeks of the program. By the end of the first month, you may see another BrightView provider for ongoing medication management. Each provider at BrightView has the same general prescribing philosophy regarding buprenorphine (MAT) but has their own individual experience and understanding of what is best for their patients.
Other Prescription Medications
Withdrawal Management Medications
Most of these medications are unlikely to be prescribed after assessment and induction. This is especially true for benzodiazepines such as valium and librium, which may be used for withdrawal management in alcohol use disorder. Upon request, other medications such as Clonidine, Phenergan, and Zofran may be continued beyond the acute withdrawal phase when appropriate.
Monthly Medications (non-buprenorphine)
For patients on non-buprenorphine medications, the prescriptions will most often be prescribed monthly. Examples of this include naltrexone (Vivitrol injection or oral formulation).